CliffBio
small molecule

DOXERCALCIFEROL

DOXERCALCIFEROL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameDOXERCALCIFEROL
Active ingredientDOXERCALCIFEROL
Strength4MCG/2ML (2MCG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2018
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.